scholarly journals Acute Hemolytic Anemia Induced by Levofloxacin in A Woman With G6PD Deficiency: A Case Report

2021 ◽  
Author(s):  
Ebrahim Salehifar ◽  
Masoud Aliyali ◽  
Aliyeh Bazi
Keyword(s):  
Case Report ◽  
Hemolytic Anemia ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Drug Induced ◽  
High Prevalence ◽  
Northern Regions ◽  
Alternative Antibiotic ◽  
Glucose 6 Phosphate Dehydrogenase ◽  
Possible Cause

Introduction: Glucose 6-Phosphate Dehydrogenase deficiency (G6PD) is an X-linked recessive disorder recognized as the most prevalent enzyme deficiency around the world. G6PD deficiency has a high prevalence in Iran, especially in the northern regions. As we know, hemolysis in G6PD patients was not reported with levofloxacin previously. Case Report: In this report, we introduce a 54-year-old G6PD deficient woman who experienced the symptoms of hemolytic anemia following completion of treatment with levofloxacin. Result: After ruling out other causes of hemolysis, by using the Naranjo scale, levofloxacin was considered as a possible cause of hemolysis. Conclusion: Though the hemolytic anemia induced by levofloxacin is extremely rare in G6PD deficient patients, drug-induced hemolytic anemia should be considered as one of the differential diagnoses. It would be appropriate to use an alternative antibiotic instead of levofloxacin in a G6PD deficient patient.  

scholarly journals Dental Considerations in Children with Glucose-6-phosphate Dehydrogenase Deficiency (Favism): A Review of the Literature and Case Report

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Daniela Hernández-Pérez ◽  
Claudia Butrón-Téllez Girón ◽  
Socorro Ruiz-Rodríguez ◽  
Arturo Garrocho-Rangel ◽  
Amaury Pozos-Guillén
Keyword(s):  
Case Report ◽  
Infectious Diseases ◽  
Hemolytic Anemia ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Present Report ◽  
Review Of The Literature ◽  
Oxidizing Agents ◽  
Dental Management ◽  
Glucose 6 Phosphate Dehydrogenase

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an uncommon inherited enzyme deficiency characterized by hemolytic anemia, caused by the inability of erythrocytes to detoxify oxidizing agents such as drugs, infectious diseases, or fava bean ingestion. In this later case, the disorder is known as favism. The aim of the present report was to present a review of the literature in this disease, to describe a case report concerning an affected 9-year-old male, and to review the main implications and precautions in pediatric dental management.

scholarly journals Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone

Blood ◽  
2012 ◽  
Vol 120 (20) ◽  
pp. 4123-4133 ◽  
Author(s):  
Allan Pamba ◽  
Naomi D. Richardson ◽  
Nick Carter ◽  
Stephan Duparc ◽  
Zul Premji ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Hemolytic Anemia ◽  
G6pd Deficiency ◽  
Case Reports ◽  
Drug Induced ◽  
Once Daily ◽  
Maximum Decrease ◽  
Life Threatening ◽  
The Mean ◽  
Glucose 6 Phosphate Dehydrogenase

AbstractDrug-induced acute hemolytic anemia led to the discovery of G6PD deficiency. However, most clinical data are from isolated case reports. In 2 clinical trials of antimalarial preparations containing dapsone (4,4′-diaminodiphenylsulfone; 2.5 mg/kg once daily for 3 days), 95 G6PD-deficient hemizygous boys, 24 G6PD-deficient homozygous girls, and 200 girls heterozygous for G6PD deficiency received this agent. In the first 2 groups, there was a maximum decrease in hemoglobin averaging −2.64 g/dL (range −6.70 to +0.30 g/dL), which was significantly greater than for the comparator group receiving artemether-lumefantrine (adjusted difference −1.46 g/dL; 95% confidence interval −1.76, −1.15). Hemoglobin concentrations were decreased by ≥ 40% versus pretreatment in 24/119 (20.2%) of the G6PD-deficient children; 13/119 (10.9%) required blood transfusion. In the heterozygous girls, the mean maximum decrease in hemoglobin was −1.83 g/dL (range +0.90 to −5.20 g/dL); 1 in 200 (0.5%) required blood transfusion. All children eventually recovered. All the G6PD-deficient children had the G6PD A− variant, ie, mutations V68M and N126D. Drug-induced acute hemolytic anemia in G6PD A− subjects can be life-threatening, depending on the nature and dosage of the drug trigger. Therefore, contrary to current perception, in clinical terms the A− type of G6PD deficiency cannot be regarded as mild. This study is registered at http://www.clinicaltrials.gov as NCT00344006 and NCT00371735.

scholarly journals General Anesthesia in a Glucose-6-Phosphate Dehydrogenase Deficiency Child: A Case Report

2019 ◽  
Vol 66 (2) ◽  
pp. 94-96
Author(s):  
Takahiro Goi ◽  
Yoshiki Shionoya ◽  
Katsuhisa Sunada ◽  
Kiminari Nakamura
Keyword(s):  
Case Report ◽  
High Risk ◽  
General Anesthesia ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Risk Group ◽  
High Risk Group ◽  
Antioxidant Effect ◽  
Attending Physician ◽  
Glucose 6 Phosphate Dehydrogenase

We performed general anesthesia on a 3-year-old boy with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients with G6PD deficiency exhibit jaundice and anemia due to hemolysis caused by a lack of the G6PD enzyme. To maintain anesthesia, we used propofol and remifentanil, which may prevent hemolytic attacks by exerting an antioxidant effect. In addition, because the patient was in a high-risk group for the development of methemoglobinemia, we used mepivacaine as a local anesthetic. We liaised with the patient's attending physician to make sufficient arrangements, such as securing an emergency transfer on the day of anesthesia. The patient did not develop hemolytic attacks during or after the procedure, and he progressed well without problems.

scholarly journals Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency

2017 ◽  
Vol 22 (6) ◽  
pp. 471-471 ◽  
Author(s):  
Manzilat Akande ◽  
Anthony N. Audino ◽  
Joseph D. Tobias
Keyword(s):  
Hemolytic Anemia ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Tumor Lysis Syndrome ◽  
Turnaround Time ◽  
Lymphoblastic Lymphoma ◽  
Test Results ◽  
Tumor Lysis ◽  
Prevention And Treatment ◽  
Glucose 6 Phosphate Dehydrogenase

Rasburicase, used in the prevention and treatment of tumor lysis syndrome (TLS), may cause hemolytic anemia and methemoglobinemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Although routine screening for G6PD deficiency has been recommended, given the turnaround time for test results and the urgency to treat TLS, such screening may not be feasible. We report a case of rasburicase-induced hemolytic anemia without methemoglobinemia in an adolescent with T-cell lymphoblastic lymphoma, TLS, and previously unrecognized G6PD deficiency. Previous reports of hemolytic anemia with rasburicase are reviewed, mechanisms discussed, and preventative strategies presented.

scholarly journals Anaesthesia for a child with glucose-6-phosphate-dehydrogenase deficiency: a case report

2020 ◽  
Vol 6 (12) ◽  
pp. 526
Author(s):  
Baththirange Malaka Munasinghe ◽  
Srisothinathan Nimalan ◽  
Nishanthan Subramaniam ◽  
Sonali Goonetilleke
Keyword(s):  
Oxidative Stress ◽  
Case Report ◽  
General Anaesthesia ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Perioperative Period ◽  
Postoperative Monitoring ◽  
Successful Case ◽  
Operative Planning ◽  
Glucose 6 Phosphate Dehydrogenase

<p class="abstract">Patients with glucose-6-phosphate-dehydrogenase (G6PD) deficiency are prone to acute haemolytic crisis during perioperative period, precipitated by oxidative stress and certain medications, which are common concurrences during this period. Careful peri-operative planning, judicious use of medication and postoperative monitoring plays a pivotal role in preventing complications in these patients. Here, we report a successful case of general anaesthesia in a child with G6PD deficiency.  </p>

scholarly journals Dental Management in a Child Patient with Glucose-6-phosphate Dehydrogenase Deficiency : A Case Report

2021 ◽  
Vol 48 (3) ◽  
pp. 359-366
Author(s):  
Jiyoon Jeon ◽  
Sunmi Yang ◽  
Namki Choi ◽  
Seonmi Kim
Keyword(s):  
Case Report ◽  
G6pd Deficiency ◽  
Dehydrogenase Deficiency ◽  
Pediatric Dentistry ◽  
Accurate Knowledge ◽  
Dental Management ◽  
Child Patient ◽  
Pediatric Dentists ◽  
Glucose 6 Phosphate Dehydrogenase ◽  
Appropriate Education

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder and is the most common enzyme deficiency worldwide. Although this disease is rare in Korea, its prevalence may increase due to an increase of multicultural families. Patients with this deficiency are prone to hemolytic anemia provoked by specific drugs commonly used or prescribed in pediatric dentistry. It is necessary for pediatric dentists to have accurate knowledge of a patient's medical history and to consult with a pediatric hematologist to avoid oxidative stress that can lead to hemolysis. The most effective treatment is prevention of exposure to factors that may trigger anemia. Appropriate education regarding risk factors is essential for patients diagnosed with this disease. This case report aimed to discuss the drugs and dental management methods that should be cautious in children with G6PD deficiency.

scholarly journals PO 8527 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND ASSOCIATION WITH UNCOMPLICATED MALARIA IN CONGOLESE CHILDREN CONSULTING IN A PAEDIATRIC HOSPITAL IN BRAZZAVILLE

2019 ◽  
Vol 4 (Suppl 3) ◽  
pp. A49.3-A50
Author(s):  
Nerly S Gampio Gueye ◽  
Velavan P Thirumalaisamy ◽  
Christevy Vouvoungui ◽  
Simon Ch Kobawila ◽  
David Nderu ◽  
...  
Keyword(s):  
G6pd Deficiency ◽  
Uncomplicated Malaria ◽  
Dehydrogenase Deficiency ◽  
Haemoglobin Concentration ◽  
Public Health Problem ◽  
Malaria Prevalence ◽  
Paediatric Hospital ◽  
High Prevalence ◽  
Republic Of The Congo ◽  
Glucose 6 Phosphate Dehydrogenase

BackgroundMalaria remains a public health problem in Republic of the Congo. The sub-microscopic infection including gametocytaemia constitutes a parasite reservoir that is recognised to contribute to malaria transmission. It is known that primaquine, an 8-aminoquinoline, is effective to eliminate Plasmodium falciparum (Pf) gametocytes. However, it induces haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (G6PDd). It has been reported G6PDd also confers protection against severe malaria. To know the prevalence of G6PDd in the Congolese population is important in the case of future utilisation of this drug in the country. Therefore, in this study, we investigated 1) the prevalence of G6PDd in children infected with Pf and 2) the possible association between the presence of malaria, the presence of G6PD mutation and haemoglobin concentration.Methods229 children aged 1 to 10 years old presenting with fever (axillary T°≥37.5°C) were enrolled at the paediatric hospital Marien Ngouabi in Brazzaville. Thick and thin blood smears were done to detect and identify malaria parasites and determine parasite density. To detect the different glucose-6-phosphate dehydrogenase genotypes, a 968 bp fragment of the G6PD gene containing the polymorphisms 202G&gt1;A and 376&gt1;G was amplified by PCR followed by sequencing.ResultsMalaria prevalence was 22 (10%). With regard to G6PD analysis, it was found that 206 patients had G6PD genotype available including 74.8% (154/206) with G6PD normal, 12.1% (25/206) with heterozygous genotypes and 13.1% (27/206) with G6PD deficiency [11.6% (24/206) were male hemizygous and 1.4% (3/206) were female homozygous]. Data are further analysed to investigate the association between G6PD genotype, uncomplicated malaria, haemoglobin concentration as well as parasite densities.ConclusionA high prevalence of G6PD deficiency is reported for these Congolese children. Further investigation with larger sample size in different areas of the country is needed to design future and adapted interventions.

scholarly journals 523 A Case Report; Brucellosis Triggering Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency

2012 ◽  
Vol 97 (Suppl 2) ◽  
pp. A152-A152
Author(s):  
M. Ozkale ◽  
Y. Ozkale ◽  
A. Erbay ◽  
U. Paltaci ◽  
S. Asilsoy
Keyword(s):  
Case Report ◽  
Hemolytic Anemia ◽  
Dehydrogenase Deficiency ◽  
Glucose 6 Phosphate Dehydrogenase
Sign in / Sign up

Export Citation Format

Share Document